Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sanofi S.A. ADR

Start price
Target price
Perf. (%)
€49.40
27.03.23
€55.60
27.03.24
-7.69%
28.03.24

buy
Sanofi S.A. ADR

Start price
Target price
Perf. (%)
€49.40
27.03.23
-
27.03.24
-7.69%
28.03.24

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€95.40
23.03.23
€100.00
23.03.24
-6.93%
24.03.24

Could be worthwhile Investment >10% per year
buy
Inventiva SA

Start price
Target price
Perf. (%)
€3.71
17.03.24
€5.00
31.01.26
-2.70%
19.03.24

Could be very worthwhile Investment >20% year
Valneva SE

Start price
Target price
Perf. (%)
€8.01
05.09.22
-
05.10.26
-57.57%
11.03.24

Probably not worthwhile Investment
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.89
30.12.23
€5.50
30.12.24
-22.39%
10.02.24

Could be worthwhile Investment >10% per year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€89.65
28.01.23
€104.00
28.01.24
3.27%
29.01.24

Cellectis Nom.

Start price
Target price
Perf. (%)
€1.26
16.10.23
-
16.10.24
95.87%
19.01.24

Risky Investment
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€1.51
27.11.23
-
27.11.24
4.25%
11.12.23

Probably not worthwhile Investment
Cerenis Therapeutics Holding S.A.

Start price
Target price
Perf. (%)
€1.19
29.05.23
-
29.05.24
12.08%
11.12.23

Probably not worthwhile Investment
buy
Adocia

Start price
Target price
Perf. (%)
€8.54
02.10.23
-
02.10.24
-3.28%
10.12.23

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€2.10
01.11.23
€2.50
01.11.24
-25.24%
09.12.23

Could be worthwhile Investment >10% per year
Adocia

Start price
Target price
Perf. (%)
€8.39
25.11.23
€4.00
25.11.24
-1.55%
09.12.23

Probably not worthwhile Investment
High valuation
Little Investments for future growth
Below average Management
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.04
12.11.22
€4.50
12.11.23
5.82%
13.11.23

Could be worthwhile Investment >10% per year
Cellectis Nom.

Start price
Target price
Perf. (%)
€1.96
01.11.23
€1.00
01.11.24
20.31%
11.11.23

Good culture
Below average Management
Few uniques
Probably not worthwhile Investment
Cellectis Nom.

Start price
Target price
Perf. (%)
€2.39
01.11.23
-
01.11.24
-1.42%
10.11.23

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€2.81
24.12.22
-
24.12.23
-25.37%
01.11.23

Could be worthwhile Investment >10% per year
buy
Inventiva SA

Start price
Target price
Perf. (%)
€6.02
27.10.22
-
27.10.23
-42.03%
28.10.23

Could be worthwhile Investment >10% per year
Carmat

Start price
Target price
Perf. (%)
€12.25
22.10.22
€10.00
22.10.23
-72.94%
23.10.23

Could be worthwhile Investment >10% per year
buy
Valbiotis

Start price
Target price
Perf. (%)
€4.97
05.10.22
€5.50
05.10.23
17.51%
06.10.23

Could be worthwhile Investment >10% per year
buy
Eurobio scientific

Start price
Target price
Perf. (%)
€17.24
05.10.22
€18.00
05.10.23
-24.25%
06.10.23

Could be worthwhile Investment >10% per year
Adocia

Start price
Target price
Perf. (%)
€9.86
16.09.23
€4.00
16.09.24
-22.11%
30.09.23

Probably not worthwhile Investment
High valuation
Little Investments for future growth
Below average Management
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€1.32
08.09.23
-
08.09.24
10.08%
15.09.23

Could be very worthwhile Investment >20% year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€79.36
11.08.22
€110.00
11.08.23
22.37%
12.08.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Cellectis Nom.

Start price
Target price
Perf. (%)
€3.52
07.08.22
€3.80
07.08.23
-52.13%
08.08.23

Could be worthwhile Investment >10% per year